Literature DB >> 23455367

Cardiac papillary fibroelastoma: retrospective clinicopathologic study of 17 tumors with resection at a single institution and literature review.

José Fernando Val-Bernal1, Marta Mayorga, María Francisca Garijo, Daniel Val, Juan Francisco Nistal.   

Abstract

Cardiac papillary fibroelastomas (PFEs), which are mainly found in the valves, are rare benign tumors that can cause embolism. Single-center surgical experience in the treatment of this tumor is uncommon. All patients surgically treated for this neoplasm at our institution from January 1995 to October 2012 (15 patients with 17 lesions) were queried for clinical and pathologic characteristics, and the literature was reviewed. The mean age of detection was 55.8±11.48 years. Twenty percent of the patients were male. The tumor was an incidental finding in 60%. Symptoms directly related to PFEs occurred in 40% of patients. The most common clinical presentation in symptomatic cases was embolism (40%), mostly transient ischemic attack or stroke. Cardiac valves were predominantly involved (76.5%); the most commonly valve affected was the aortic valve (29.4%), followed by the mitral valve (17.6%). Concurrent valvular disease was observed in 41.7% of patients. The mean size of tumors was 11.4±7.9mm (range 2-25mm). In 86.7% of the patients, the tumor was solitary. The mitral valve was the most common origin of tumor systemic embolism. Fronds core could be the end stage of hypermature elastic fibers, which grows in apposition to young fibers. Simple surgical excision or valvular reconstruction was accomplished in most patients (58.3%). PFE is usually small, appears singly, and can cause potentially serious complications. Symptomatic and left side tumors should undergo surgical excision with valve-spare surgery when possible. Surgical removal of PFE is safe, efficacious, and definitive.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23455367     DOI: 10.1016/j.prp.2013.02.001

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  Incidental cardiac papillary fibroelastoma: a management dilemma.

Authors:  Lovely Chhabra; Saurabh Joshi; Vinod Kumar Chaubey; Sudesh Kaul
Journal:  BMJ Case Rep       Date:  2013-08-07

2.  Ominous Etiology of Blurry Vision.

Authors:  Joseph Zachariah; Parul Nijhawan; Sunil Manjila
Journal:  Neurohospitalist       Date:  2016-05-11

3.  Papillary fibroelastoma, an unexpected cause of stroke: Outcomes after acute reperfusion therapy.

Authors:  Ana Moreno-Estébanez; Alain Luna Rodríguez; Iratxe Ugarriza Serrano; Elisa Blanco Martín; Tirso González-Pinto; Jagoba Larrazabal López; Tomás Pérez-Concha
Journal:  Neurol Clin Pract       Date:  2018-06

4.  Identification and clinical course of 166 pediatric cardiac tumors.

Authors:  Lin Shi; Lanping Wu; Huijuan Fang; Bo Han; Jialun Yang; Xiaojin Ma; Fang Liu; Yongwei Zhang; Tingting Xiao; Min Huang; Meirong Huang
Journal:  Eur J Pediatr       Date:  2017-01-10       Impact factor: 3.183

5.  Pulmonary Eosinophilic Inflammatory Infiltration Post-Intensive Care in a Nearly Drowned Young Man with Papillary Fibroelastoma: A Rare Complication Discovered by Forensic Autopsy.

Authors:  Gelsomina Mansueto; Emanuele Capasso; Claudio Buccelli; Massimo Niola
Journal:  Front Med (Lausanne)       Date:  2018-01-15

6.  KRAS mutation in papillary fibroelastoma: a true cardiac neoplasm?

Authors:  Maike Wittersheim; Carina Heydt; Fabian Hoffmann; Reinhard Büttner
Journal:  J Pathol Clin Res       Date:  2017-03-07

7.  Papillary fibroelastoma, unusual cause of stroke in a young man: a case report.

Authors:  Elisabetta Grolla; Michele Dalla Vestra; Giampaolo Zoffoli; Riccardo D'Ascoli; Adriana Critelli; Rocco Quatrale; Domenico Mangino; Fausto Rigo
Journal:  J Cardiothorac Surg       Date:  2017-05-19       Impact factor: 1.637

8.  Subaortic Membrane Papillary Fibroelastoma.

Authors:  Robyn Bryde; Kevin Landolfo; Jordan C Ray; Pragnesh Parikh; Qihui Jim Zhai; Carolyn Landolfo
Journal:  Case Rep Cardiol       Date:  2020-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.